Asston Pharmaceuticals Limited (BOM:544445)
India · Delayed Price · Currency is INR 82.00
+4.00 (5.13%)
At close: Jun 17, 2026
Asston Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 254.69 | 250.39 | 155.86 | 65.38 | 95.99 |
Other Revenue | 61.16 | - | - | - | - |
| 315.84 | 250.39 | 155.86 | 65.38 | 95.99 | |
Revenue Growth (YoY) | 26.14% | 60.65% | 138.39% | -31.89% | 19.47% |
Cost of Revenue | 174.13 | 141.44 | 97.54 | 33.49 | 76.74 |
Gross Profit | 141.72 | 108.96 | 58.32 | 31.89 | 19.25 |
Selling, General & Admin | 26.38 | 15.02 | 8.81 | 5.93 | 6.18 |
Other Operating Expenses | 59.84 | 29.98 | 16.61 | 10.79 | 16.62 |
Operating Expenses | 89.46 | 45.81 | 25.92 | 17.09 | 22.89 |
Operating Income | 52.26 | 63.14 | 32.4 | 14.8 | -3.64 |
Interest Expense | -6.33 | -7.98 | -9.01 | -6.76 | -4.25 |
Interest & Investment Income | - | 0.87 | 1.21 | 0.51 | 0 |
Currency Exchange Gain (Loss) | - | -2.36 | -7.45 | 5.11 | 7.45 |
Other Non Operating Income (Expenses) | - | 3.32 | 1.02 | 0.47 | 2.02 |
Pretax Income | 45.93 | 57 | 18.17 | 14.13 | 1.59 |
Income Tax Expense | 7.28 | 13.75 | 4.57 | 3.56 | 0.48 |
Net Income | 38.65 | 43.25 | 13.6 | 10.57 | 1.11 |
Net Income to Common | 38.65 | 43.25 | 13.6 | 10.57 | 1.11 |
Net Income Growth | -10.63% | 217.95% | 28.74% | 855.34% | 20.70% |
Shares Outstanding (Basic) | 8 | 6 | 6 | 6 | 0 |
Shares Outstanding (Diluted) | 8 | 6 | 6 | 6 | 0 |
Shares Change (YoY) | 25.27% | 11.99% | - | 5783.59% | 18.98% |
EPS (Basic) | 4.92 | 6.90 | 2.43 | 1.89 | 11.63 |
EPS (Diluted) | 4.92 | 6.90 | 2.37 | 1.89 | 11.62 |
EPS Growth | -28.66% | 191.00% | 25.61% | -83.76% | 1.45% |
Free Cash Flow | -202.42 | -1.63 | -38.11 | -5.67 | -11.89 |
Free Cash Flow Per Share | -25.77 | -0.26 | -6.80 | -1.01 | -124.88 |
Gross Margin | 44.87% | 43.51% | 37.42% | 48.77% | 20.05% |
Operating Margin | 16.55% | 25.22% | 20.79% | 22.63% | -3.79% |
Profit Margin | 12.24% | 17.27% | 8.73% | 16.16% | 1.15% |
Free Cash Flow Margin | -64.09% | -0.65% | -24.45% | -8.67% | -12.38% |
EBITDA | 55.5 | 63.95 | 32.9 | 15.17 | -3.55 |
EBITDA Margin | 17.57% | 25.54% | 21.11% | 23.20% | -3.70% |
D&A For EBITDA | 3.24 | 0.81 | 0.51 | 0.37 | 0.08 |
EBIT | 52.26 | 63.14 | 32.4 | 14.8 | -3.64 |
EBIT Margin | 16.55% | 25.22% | 20.79% | 22.63% | -3.79% |
Effective Tax Rate | 15.85% | 24.12% | 25.14% | 25.20% | 30.40% |
Revenue as Reported | 315.84 | 256.1 | 158.41 | 71.92 | 105.55 |